STOCK ALARM
SA
Menu
Demo
Log In
Atlas
News
Feed
Alerts
Portfolio
Screener
Picks
Charts
Movers
Earnings
Updates
ADAP
(ADAP)
ADAP
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Per Share (TTM)
Revenue/Share
$0.48
Net Income/Share
$-1.77
Operating CF/Share
$-2.30
Free CF/Share
$-2.30
Cash/Share
$0.59
Book Value/Share
$-1.61
Tangible Book/Share
$-1.70
Equity/Share
$-1.61
Interest Debt/Share
$1.17
CapEx/Share
$0.03
Dividend/Share
$0.00
Valuation
Market Cap
$8.75M
Enterprise Value
$31.37M
P/E Ratio
-0.11
P/S Ratio
0.42
P/OCF Ratio
-0.09
P/FCF Ratio
-0.09
P/B Ratio
-0.12
P/TB Ratio
-0.12
EV/Sales
1.50
EV/EBITDA
-0.46
Graham Valuation
Graham Number
--
Graham Net-Net
$-3.37
Profitability
Earnings Yield
-894.15%
FCF Yield
-1159.83%
ROE
143.79%
ROIC
-86.24%
Return on Tangible Assets
-61.44%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-1.26%
CapEx/Revenue
6.10%
CapEx/Depreciation
0.26
SBC/Revenue
9.49%
SG&A/Revenue
196.53%
R&D/Revenue
247.29%
Liquidity & Solvency
Debt/Equity
-0.69
Debt/Assets
0.37
Debt/Market Cap
5.57
Net Debt/EBITDA
-0.33
Current Ratio
1.52
Interest Coverage
-26.74x
Income Quality
1.30
Efficiency
Days Sales Outstanding
503 days
Days Payables Outstanding
1017 days
Days Inventory
1232 days
Receivables Turnover
0.73x
Payables Turnover
0.36x
Inventory Turnover
0.30x
Capital Structure
Tangible Assets
-$74.77M
Working Capital
$26.60M
Invested Capital
$77.31M
Intangibles/Assets
2.91%
Adaptimmune Therapeutics plc
(ADAP)
$0.05
—
Chart
Share
Post on X
ADAP
Adaptimmune Therapeutics plc
(ADAP)
NASDAQ
$0.05
—
Chart Studio
Share
ADAP